MedPath

To compare carotid blood vessel ultrasound examination and FloTrac instrument for assessing the function of heart during liver transplantation surgery.

Not yet recruiting
Conditions
End stage liver disease patients undergoing liver transplantation surgery
Registration Number
CTRI/2018/02/012080
Lead Sponsor
Dept of Anaesthesia I L B S
Brief Summary

The primary purpose of this trial to authenticate cardiac output and fluid responsiveness measurements obtained with carotid Doppler assessment by correlating with an already existing hemodynamic monitoring technique like FloTrac during liver transplantation surgery. There are many challenges posed by this complex surgery and liver disease itself in accurate hemodynamic assessment. Existing methods donot accurately assess hemodynamic status due to these limitations eg. high vasopressors after reperfusion. Our hypothesis is that carotid artery is a site which is minimally affected by liver disease and the difficulties of liver transplant surgery. So this site can be used for hemodynamic assessment with a non-invasive modality like ultrasound during liver transplant.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

all end stage liver disease patients undergoing liver transplantation surgery.

Exclusion Criteria

Age less than 18 years pregnancy Rhythm disturbances pre-operative and intra-operative dialysis.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Correlation of cardiac output and stroke volume variation obtained with FloTrac and Carotid artery Doppler derived Cardiac output and FlowtimeImmediately after induction of anaesthesia, 1 hour into dissection phase, 3 hours into dissection phase, anhepatic phase, post-reperfusion phase
Secondary Outcome Measures
NameTimeMethod
Effect of vasopressors, hemoglobin on discrepancy of cardiac output measurements between two methodsImmediately after induction of anaesthesia, 1 hour into dissection phase, 3 hours into dissection phase, anhepatic phase, post-reperfusion phase

Trial Locations

Locations (1)

Institute of liver and Biliary Sciences

🇮🇳

South, DELHI, India

Institute of liver and Biliary Sciences
🇮🇳South, DELHI, India
Nandakumar K
Principal investigator
7835056142
drnandakumarmd@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.